HRP20170773T1 - Novi anti-malarijski agensi - Google Patents
Novi anti-malarijski agensi Download PDFInfo
- Publication number
- HRP20170773T1 HRP20170773T1 HRP20170773TT HRP20170773T HRP20170773T1 HR P20170773 T1 HRP20170773 T1 HR P20170773T1 HR P20170773T T HRP20170773T T HR P20170773TT HR P20170773 T HRP20170773 T HR P20170773T HR P20170773 T1 HRP20170773 T1 HR P20170773T1
- Authority
- HR
- Croatia
- Prior art keywords
- pyrazole derivative
- fluorophenyl
- methyl
- pyrazol
- image
- Prior art date
Links
- 239000003430 antimalarial agent Substances 0.000 title claims 2
- 150000003217 pyrazoles Chemical class 0.000 claims 11
- 239000008194 pharmaceutical composition Substances 0.000 claims 4
- BLUAFEHZUWYNDE-NNWCWBAJSA-N artemisinin Chemical group C([C@](OO1)(C)O2)C[C@H]3[C@H](C)CC[C@@H]4[C@@]31[C@@H]2OC(=O)[C@@H]4C BLUAFEHZUWYNDE-NNWCWBAJSA-N 0.000 claims 3
- 239000003795 chemical substances by application Substances 0.000 claims 3
- 150000003839 salts Chemical class 0.000 claims 3
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 claims 2
- LOUPRKONTZGTKE-WZBLMQSHSA-N Quinine Chemical compound C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-WZBLMQSHSA-N 0.000 claims 2
- 229960003722 doxycycline Drugs 0.000 claims 2
- XQTWDDCIUJNLTR-CVHRZJFOSA-N doxycycline monohydrate Chemical compound O.O=C1C2=C(O)C=CC=C2[C@H](C)[C@@H]2C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]1[C@H]2O XQTWDDCIUJNLTR-CVHRZJFOSA-N 0.000 claims 2
- 201000004792 malaria Diseases 0.000 claims 2
- OLMXEDHUPRLENN-UHFFFAOYSA-N n-[4-(4-chloro-2-fluorophenyl)-2-methyl-5-(trifluoromethyl)pyrazol-3-yl]-2-(2-propan-2-ylbenzimidazol-1-yl)acetamide Chemical compound CC(C)C1=NC2=CC=CC=C2N1CC(=O)NC(N(N=C1C(F)(F)F)C)=C1C1=CC=C(Cl)C=C1F OLMXEDHUPRLENN-UHFFFAOYSA-N 0.000 claims 2
- UCRHFBCYFMIWHC-UHFFFAOYSA-N piperaquine Chemical compound ClC1=CC=C2C(N3CCN(CC3)CCCN3CCN(CC3)C=3C4=CC=C(C=C4N=CC=3)Cl)=CC=NC2=C1 UCRHFBCYFMIWHC-UHFFFAOYSA-N 0.000 claims 2
- 229950006717 piperaquine Drugs 0.000 claims 2
- 125000003226 pyrazolyl group Chemical group 0.000 claims 2
- 239000012453 solvate Substances 0.000 claims 2
- XEEQGYMUWCZPDN-DOMZBBRYSA-N (-)-(11S,2'R)-erythro-mefloquine Chemical compound C([C@@H]1[C@@H](O)C=2C3=CC=CC(=C3N=C(C=2)C(F)(F)F)C(F)(F)F)CCCN1 XEEQGYMUWCZPDN-DOMZBBRYSA-N 0.000 claims 1
- DLIFLSQFCPOVPV-GOSISDBHSA-N (3r)-3-amino-4-(4-fluorophenyl)-n-[4-(4-fluorophenyl)-2,5-dimethylpyrazol-3-yl]butanamide Chemical compound C([C@@H](N)CC(=O)NC=1N(C)N=C(C=1C=1C=CC(F)=CC=1)C)C1=CC=C(F)C=C1 DLIFLSQFCPOVPV-GOSISDBHSA-N 0.000 claims 1
- PFQWYPIUYQEFMH-MRXNPFEDSA-N (3r)-3-amino-4-(4-fluorophenyl)-n-[4-(4-fluorophenyl)-2-methyl-5-(trifluoromethyl)pyrazol-3-yl]butanamide Chemical compound C([C@@H](N)CC(=O)NC1=C(C(=NN1C)C(F)(F)F)C=1C=CC(F)=CC=1)C1=CC=C(F)C=C1 PFQWYPIUYQEFMH-MRXNPFEDSA-N 0.000 claims 1
- WHTVZRBIWZFKQO-AWEZNQCLSA-N (S)-chloroquine Chemical compound ClC1=CC=C2C(N[C@@H](C)CCCN(CC)CC)=CC=NC2=C1 WHTVZRBIWZFKQO-AWEZNQCLSA-N 0.000 claims 1
- IOTAOYHKWICOBK-UHFFFAOYSA-N 1-[amino-(4-chloroanilino)methylidene]-2-propan-2-ylguanidine;3-[4-(4-chlorophenyl)cyclohexyl]-4-hydroxynaphthalene-1,2-dione;hydrochloride Chemical compound Cl.CC(C)N=C(N)\N=C(/N)NC1=CC=C(Cl)C=C1.O=C1C(=O)C2=CC=CC=C2C(O)=C1C(CC1)CCC1C1=CC=C(Cl)C=C1 IOTAOYHKWICOBK-UHFFFAOYSA-N 0.000 claims 1
- SARMGXPVOFNNNG-UHFFFAOYSA-N 1-[amino-(4-chloroanilino)methylidene]-2-propan-2-ylguanidine;hydron;chloride Chemical compound Cl.CC(C)N=C(N)N=C(N)NC1=CC=C(Cl)C=C1 SARMGXPVOFNNNG-UHFFFAOYSA-N 0.000 claims 1
- LUBUTTBEBGYNJN-UHFFFAOYSA-N 4-amino-n-(5,6-dimethoxypyrimidin-4-yl)benzenesulfonamide;5-(4-chlorophenyl)-6-ethylpyrimidine-2,4-diamine Chemical compound CCC1=NC(N)=NC(N)=C1C1=CC=C(Cl)C=C1.COC1=NC=NC(NS(=O)(=O)C=2C=CC(N)=CC=2)=C1OC LUBUTTBEBGYNJN-UHFFFAOYSA-N 0.000 claims 1
- DLYPREQTTOHKSM-UHFFFAOYSA-N 7-chloro-n-[[2-[(dimethylamino)methyl]cyclopenta-1,4-dien-1-yl]methyl]quinolin-4-amine;cyclopenta-1,3-diene;iron(2+) Chemical compound [Fe+2].C1C=CC=[C-]1.C1=[C-]CC(CN(C)C)=C1CNC1=CC=NC2=CC(Cl)=CC=C12 DLYPREQTTOHKSM-UHFFFAOYSA-N 0.000 claims 1
- OVCDSSHSILBFBN-UHFFFAOYSA-N Amodiaquine Chemical compound C1=C(O)C(CN(CC)CC)=CC(NC=2C3=CC=C(Cl)C=C3N=CC=2)=C1 OVCDSSHSILBFBN-UHFFFAOYSA-N 0.000 claims 1
- 235000001258 Cinchona calisaya Nutrition 0.000 claims 1
- FOHHNHSLJDZUGQ-VWLOTQADSA-N Halofantrine Chemical compound FC(F)(F)C1=CC=C2C([C@@H](O)CCN(CCCC)CCCC)=CC3=C(Cl)C=C(Cl)C=C3C2=C1 FOHHNHSLJDZUGQ-VWLOTQADSA-N 0.000 claims 1
- LBHLFPGPEGDCJG-UHFFFAOYSA-N N(4)-{2,6-dimethoxy-4-methyl-5-[3-(trifluoromethyl)phenoxy]quinolin-8-yl}pentane-1,4-diamine Chemical compound COC=1C=C(NC(C)CCCN)C2=NC(OC)=CC(C)=C2C=1OC1=CC=CC(C(F)(F)F)=C1 LBHLFPGPEGDCJG-UHFFFAOYSA-N 0.000 claims 1
- 208000030852 Parasitic disease Diseases 0.000 claims 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims 1
- 229960001444 amodiaquine Drugs 0.000 claims 1
- 230000000078 anti-malarial effect Effects 0.000 claims 1
- 229960000981 artemether Drugs 0.000 claims 1
- 229960004191 artemisinin Drugs 0.000 claims 1
- 229930101531 artemisinin Natural products 0.000 claims 1
- 229960002521 artenimol Drugs 0.000 claims 1
- BJDCWCLMFKKGEE-ISOSDAIHSA-N artenimol Chemical compound C([C@](OO1)(C)O2)C[C@H]3[C@H](C)CC[C@@H]4[C@@]31[C@@H]2O[C@H](O)[C@@H]4C BJDCWCLMFKKGEE-ISOSDAIHSA-N 0.000 claims 1
- 229960003159 atovaquone Drugs 0.000 claims 1
- KUCQYCKVKVOKAY-CTYIDZIISA-N atovaquone Chemical compound C1([C@H]2CC[C@@H](CC2)C2=C(C(C3=CC=CC=C3C2=O)=O)O)=CC=C(Cl)C=C1 KUCQYCKVKVOKAY-CTYIDZIISA-N 0.000 claims 1
- 229940114027 atovaquone / proguanil Drugs 0.000 claims 1
- 229960003677 chloroquine Drugs 0.000 claims 1
- WHTVZRBIWZFKQO-UHFFFAOYSA-N chloroquine Natural products ClC1=CC=C2C(NC(C)CCCN(CC)CC)=CC=NC2=C1 WHTVZRBIWZFKQO-UHFFFAOYSA-N 0.000 claims 1
- LOUPRKONTZGTKE-UHFFFAOYSA-N cinchonine Natural products C1C(C(C2)C=C)CCN2C1C(O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-UHFFFAOYSA-N 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 229930016266 dihydroartemisinin Natural products 0.000 claims 1
- SXYIRMFQILZOAM-HVNFFKDJSA-N dihydroartemisinin methyl ether group Chemical group CO[C@@H]1[C@@H]([C@@H]2CC[C@H]([C@@H]3CC[C@]4(OO[C@]32[C@H](O1)O4)C)C)C SXYIRMFQILZOAM-HVNFFKDJSA-N 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 1
- 229950010451 ferroquine Drugs 0.000 claims 1
- 229960003242 halofantrine Drugs 0.000 claims 1
- 230000000415 inactivating effect Effects 0.000 claims 1
- DYLGFOYVTXJFJP-MYYYXRDXSA-N lumefantrine Chemical compound C12=CC(Cl)=CC=C2C=2C(C(O)CN(CCCC)CCCC)=CC(Cl)=CC=2\C1=C/C1=CC=C(Cl)C=C1 DYLGFOYVTXJFJP-MYYYXRDXSA-N 0.000 claims 1
- 229960004985 lumefantrine Drugs 0.000 claims 1
- 229960001962 mefloquine Drugs 0.000 claims 1
- 229960000901 mepacrine Drugs 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- AXHVMTZWSKDPRR-UHFFFAOYSA-N n-[4-(4-chloro-2-fluorophenyl)-2,5-dimethylpyrazol-3-yl]-2-(2-propan-2-ylbenzimidazol-1-yl)acetamide Chemical compound CC(C)C1=NC2=CC=CC=C2N1CC(=O)NC(N(N=C1C)C)=C1C1=CC=C(Cl)C=C1F AXHVMTZWSKDPRR-UHFFFAOYSA-N 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 229960005179 primaquine Drugs 0.000 claims 1
- INDBQLZJXZLFIT-UHFFFAOYSA-N primaquine Chemical compound N1=CC=CC2=CC(OC)=CC(NC(C)CCCN)=C21 INDBQLZJXZLFIT-UHFFFAOYSA-N 0.000 claims 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 1
- 229960001870 proguanil hydrochloride Drugs 0.000 claims 1
- DJUFPMUQJKWIJB-UHFFFAOYSA-N pyronaridine Chemical compound C12=NC(OC)=CC=C2N=C2C=C(Cl)C=CC2=C1NC(C=C(CN1CCCC1)C=1O)=CC=1CN1CCCC1 DJUFPMUQJKWIJB-UHFFFAOYSA-N 0.000 claims 1
- 229950011262 pyronaridine Drugs 0.000 claims 1
- GPKJTRJOBQGKQK-UHFFFAOYSA-N quinacrine Chemical compound C1=C(OC)C=C2C(NC(C)CCCN(CC)CC)=C(C=CC(Cl)=C3)C3=NC2=C1 GPKJTRJOBQGKQK-UHFFFAOYSA-N 0.000 claims 1
- 229960000948 quinine Drugs 0.000 claims 1
- UGOGIUREIICPLT-UHFFFAOYSA-N spiro[1h-indole-3,1'-pyrido[3,4-b]indole]-2-one Chemical compound C12=NC3=CC=CC=C3C1=CC=NC12C2=CC=CC=C2NC1=O UGOGIUREIICPLT-UHFFFAOYSA-N 0.000 claims 1
- 229910052717 sulfur Inorganic materials 0.000 claims 1
- 239000011593 sulfur Substances 0.000 claims 1
- 229950000856 tafenoquine Drugs 0.000 claims 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/38—Nitrogen atoms
- C07D231/40—Acylated on said nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Claims (14)
1. Derivat pirazola u skladu sa Formulom (I),
[image]
naznačen time što je X1 odabran od F i H; X2 je odabran od Cl i F; R1 je odabran od metila i trifluorometila; R2 je odabran od sljedećih grupa:
[image]
[image]
kao i njegova farmaceutski prihvatljiva sol, hidrat, solvat, polimorf, tautomeri, geometrijski izomeri, ili optički aktivni izomeri.
2. Derivat pirazola prema zahtjevu 1, naznačen time što je R2:
[image]
3. Derivat pirazola prema zahtjevu 1, naznačen time što je R2:
[image]
4. Derivat pirazola prema zahtjevu 1 ili 2 odabran iz sljedeće grupe:
N-(4-(4-kloro-2-fluorofenil)-3-(trifluorometil)-1-metil-1H-pirazol-5-il)-2-(2-izopropil-1H-benzo[d]imidazol-1-il)acetamid;
N-(4-(4-kloro-2-fluorofenil)-1,3-dimetil-1H-pirazol-5-il)-2-(2-izopropil-1H-benzo[d]imidazol-1-il)acetamid;
(R)-3-amino-N-(3-(trifluorometil)-4-(4-fluorofenil)-1-metil-1H-pirazol-5-il)-4-(4-fluorofenil) butanamid; i
(R)-3-amino-4-(4-fluorofenil)-N-(4-(4-fluorofenil)-1,3-dimetil-1H-pirazol-5-il)butanamid; kao i bilo koja farmaceutski prihvatljiva sol, hidrat, solvat, polimorf, tautomeri, geometrijski izomeri ili njihovi optički aktivni oblici.
5. Derivat pirazola prema bilo kojem od zahtjeva od 1 do 4, za upotrebu kao lijek.
6. Farmaceutski sastav koji sadrži najmanje jedan derivat pirazola prema bilo kojem od zahtjeva od 1 do 4 ili njegovu farmaceutski prihvatljivu sol i farmaceutski prihvatljiv nosač, diluent ili ekscipijens.
7. Farmaceutski sastav prema zahtjevu 6 koji sadrži i antimalarijski ko-agens.
8. Farmaceutski sastav prema zahtjevu 7 u kojem je ko-agens odabran od artemisinina ili derivata artemisinina, klorokvina, kinina, meflohina, amodijahina, atovakvon/proguanila, doksiciklina, lumefantrina, piperakvina, pironaridina, halofantrina, pirimetamin-sulfadoksina, primakvina, kvinakrina, doksiciklina, atovakona, proguanil hidroklorida, piperakvina, ferokvina, tafenokvina, arterolana, Spiro[3H-indol-3,1'-[1H]pirido[3,4-b]indol]-2(1H)-ona (CAS Reg Br: 1193314-23-6), 5,7'-dikloro-6'-fluoro-2',3',4',9'-tetrahidro-3'-metil-, (1'R,3'S)-], Sumpora, [4-[[2-(1,1-difluoretil)-5-metil[1,2,4]triazolo[1,5-a]pirimidin-7-il]amino]fenil]pentafluoro-] (CAS Reg. Br: 1282041-94-4), Morfolina, i 4-[2-(4-cis-dispiro[cikloheksan-1,3'-[1,2,4]trioksolan-5'2"-triciklo [3.3.1.13,7]dekan]-4-ilfenoksi)etil]-] (CAS Reg. Br.: 1029939-86-3).
9. Farmaceutski sastav prema zahtjevu 7, u kojem je derivat artemisinina artemeter ili dihidroartemisinin.
10. Derivat pirazola prema bilo kojem od zahtjeva od 1 do 4 za upotrebu u prevenciji ili liječenju malarije.
11. Derivat pirazola za upotrebu prema zahtjevu 10 pri čemu derivat pirazola treba da bude administriran u kombinaciji sa ko-agensom korisnim u liječenju malarije.
12. Derivat pirazola za upotrebu prema zahtjevu 10 ili 11, naznačen time što je derivat pirazola prema zahtjevu 4.
13. Derivat pirazola za upotrebu prema zahtjevu 10 ili 11, naznačen time što je derivat pirazola N-(4-(4 kloro-2-fluorofenil)-3-(trifluorometil)-1-metil-1H-pirazol-5-il)-2-(2-izopropil-1H-benzo[d]imidazol -1-il)acetamid.
14. Postupak ex vivo za inaktivaciju parazitske infekcije u stanici koji obuhvaća korak dovođenja u kontakt ex vivo stanice sa efikasnom količinom najmanje jednog spoja prema bilo kojem od zahtjeva 1 do 4.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361847185P | 2013-07-17 | 2013-07-17 | |
| EP14759317.2A EP3022200B1 (en) | 2013-07-17 | 2014-07-17 | New anti-malarial agents |
| PCT/IB2014/063180 WO2015008246A1 (en) | 2013-07-17 | 2014-07-17 | New anti-malarial agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20170773T1 true HRP20170773T1 (hr) | 2017-08-11 |
Family
ID=51492402
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20170773TT HRP20170773T1 (hr) | 2013-07-17 | 2017-05-23 | Novi anti-malarijski agensi |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US9464057B2 (hr) |
| EP (1) | EP3022200B1 (hr) |
| JP (1) | JP2016527228A (hr) |
| CN (1) | CN105377838A (hr) |
| CA (1) | CA2918290A1 (hr) |
| CY (1) | CY1118913T1 (hr) |
| ES (1) | ES2625160T3 (hr) |
| HK (1) | HK1219728A1 (hr) |
| HR (1) | HRP20170773T1 (hr) |
| HU (1) | HUE033124T2 (hr) |
| LT (1) | LT3022200T (hr) |
| ME (1) | ME02724B (hr) |
| PL (1) | PL3022200T3 (hr) |
| PT (1) | PT3022200T (hr) |
| RS (1) | RS55998B1 (hr) |
| SI (1) | SI3022200T1 (hr) |
| WO (1) | WO2015008246A1 (hr) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107149604A (zh) * | 2017-03-17 | 2017-09-12 | 高雪亚 | 一种治疗非酒精性脂肪肝的药物组合物 |
| PL233259B1 (pl) * | 2017-07-10 | 2019-09-30 | Politechnika Poznanska | Indolilooctany 1-alkilochininy, sposób ich otrzymywania oraz zastosowanie jako środki bakteriostatyczne i bakteriobójcze |
| EP3710492B1 (en) | 2017-11-13 | 2021-08-11 | INEOS Styrolution Group GmbH | Thermoplastic molding composition and articles made thereof having improved surface quality |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009065096A1 (en) | 2007-11-16 | 2009-05-22 | University Of Medicine And Dentistry Of New Jersey | Mechanism-based small-molecule parasite inhibitors |
-
2014
- 2014-07-17 PT PT147593172T patent/PT3022200T/pt unknown
- 2014-07-17 JP JP2016526745A patent/JP2016527228A/ja not_active Withdrawn
- 2014-07-17 US US14/905,369 patent/US9464057B2/en active Active
- 2014-07-17 ME MEP-2017-110A patent/ME02724B/me unknown
- 2014-07-17 SI SI201430230A patent/SI3022200T1/sl unknown
- 2014-07-17 PL PL14759317T patent/PL3022200T3/pl unknown
- 2014-07-17 RS RS20170488A patent/RS55998B1/sr unknown
- 2014-07-17 ES ES14759317.2T patent/ES2625160T3/es active Active
- 2014-07-17 WO PCT/IB2014/063180 patent/WO2015008246A1/en active Application Filing
- 2014-07-17 CN CN201480040428.7A patent/CN105377838A/zh active Pending
- 2014-07-17 HU HUE14759317A patent/HUE033124T2/en unknown
- 2014-07-17 EP EP14759317.2A patent/EP3022200B1/en active Active
- 2014-07-17 CA CA2918290A patent/CA2918290A1/en not_active Abandoned
- 2014-07-17 LT LTEP14759317.2T patent/LT3022200T/lt unknown
-
2016
- 2016-07-04 HK HK16107699.1A patent/HK1219728A1/zh unknown
-
2017
- 2017-05-12 CY CY20171100508T patent/CY1118913T1/el unknown
- 2017-05-23 HR HRP20170773TT patent/HRP20170773T1/hr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP3022200A1 (en) | 2016-05-25 |
| SI3022200T1 (sl) | 2017-06-30 |
| CA2918290A1 (en) | 2015-01-22 |
| ME02724B (me) | 2017-10-20 |
| PT3022200T (pt) | 2017-06-12 |
| WO2015008246A1 (en) | 2015-01-22 |
| CN105377838A (zh) | 2016-03-02 |
| US20160194286A1 (en) | 2016-07-07 |
| PL3022200T3 (pl) | 2017-08-31 |
| ES2625160T3 (es) | 2017-07-18 |
| EP3022200B1 (en) | 2017-03-01 |
| HUE033124T2 (en) | 2017-11-28 |
| LT3022200T (lt) | 2017-06-12 |
| CY1118913T1 (el) | 2018-01-10 |
| HK1219728A1 (zh) | 2017-04-13 |
| US9464057B2 (en) | 2016-10-11 |
| RS55998B1 (sr) | 2017-09-29 |
| JP2016527228A (ja) | 2016-09-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2454411C2 (ru) | Производные хинолина | |
| HRP20210459T1 (hr) | Supstituirani derivati oksopiridina | |
| HRP20200836T1 (hr) | Liječenje bolesti povezanih s imunitetom i upalnih bolesti | |
| JP2014511893A5 (hr) | ||
| HRP20170773T1 (hr) | Novi anti-malarijski agensi | |
| RU2016110483A (ru) | Производные пирролопиридина или пиразолопиридина | |
| JP2010531345A5 (hr) | ||
| HRP20150082T1 (hr) | Derivati pirazolo piridina kao inhibitori nadph oksidaze | |
| RU2015148189A (ru) | ПРОИЗВОДНЫЕ 2-АМИДОПИРИДО[4, 3-d]ПИРИМИДИН-5-ОНА И ИХ ПРИМЕНЕНИЕ В КАЧЕСТВЕ ИНГИБИТОРОВ WEE-1 | |
| RU2009148673A (ru) | Производные пиразинона и их применение для лечения легочных заболеваний | |
| JP2013516395A5 (hr) | ||
| DK2840080T3 (da) | Nitrogenholdig heterocyklisk forbindelse eller salt deraf | |
| JP2019505541A5 (hr) | ||
| NZ593295A (en) | Preparation method of dihydroindene amide compounds, their pharmaceutical compositions containing compounds thereof and use as protein kinase inhibitor | |
| NZ612544A (en) | Heterocyclic compounds suitable for the treatment of dyslipidemia | |
| JP2009541223A5 (hr) | ||
| NZ597241A (en) | Pharmaceutical dosage form for oral administration of a bcl-2 family inhibitor | |
| UY30906A1 (es) | Productos farmaceuticos comprendiendo primer ingrediente activo n-[2-(dietilamino)-n-(2-{[2-(4-hidroxi-2-oxo-2,3-dihidro-1,3-benziotazol-7-il)etil)-3-[2-(1-nafti)etoxi]propanamida o una sal y un segundo seleccionado de un grupo especifico | |
| HRP20171515T1 (hr) | Spojevi fenoksietilpiperidina | |
| US20100197666A1 (en) | (thio) -carbamoyl-cyclohexane derivatives and method for treating schizophrenia | |
| HRP20140151T1 (hr) | Derivati spiro-indola za lijeäśenje parazitnih bolesti | |
| RU2019135834A (ru) | Терапевтическое средство для лечения деменции, представляющее собой комбинацию производного пиразолохинолина и донепезила | |
| JP2020529998A5 (hr) | ||
| JP2013505930A5 (hr) | ||
| DOP2012000053A (es) | Derivados de (tio) morfolina como moduladores de s1p |